Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer.
Prostate Cancer Prostatic Dis
; 24(1): 61-68, 2021 03.
Article
in En
| MEDLINE
| ID: mdl-32123315
Full text:
1
Database:
MEDLINE
Main subject:
Phenelzine
/
Prostatic Neoplasms
/
Adenocarcinoma
/
Prostate-Specific Antigen
/
Neoplasm Recurrence, Local
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Prostate Cancer Prostatic Dis
Journal subject:
ENDOCRINOLOGIA
/
NEOPLASIAS
/
UROLOGIA
Year:
2021
Type:
Article
Affiliation country:
United States